MS Causes

drugs

Drugs and MS: A Sad (But True) Story – Medication Costs Increase 25.4% in 2010

0
“The total amount spent on MS medications increased 25.4% from 2009-2010.  The amount had increased 34.4% from 2008-2009 and 18.3% from 2007-2008.  The result is an amount spent in 2010 on MS medications which is double what what spent in 2007.  Double in three years.  If forecasts are correct, the amount spent on MS drugs will more than double again in three years.Much of this increase is due to an increase in the price of each medication.  The price for Copaxone was increased 19% according to the 2010 Drug Trend Report, while utilization for MS drugs is actually decreasing slightly. 

More >

6 months after CCSVI and 4,5 years on Dr Klenner’s protocol

CCSVI_MS

This is MS: Video Facts and more… on CCSVI

Many many facts about ccsvi and liberation. Before and after Videos. Πολλές μαρτυρίες σχετικά με τη ΧΕΝΦΑ πριν και μετά.

http://www.thisisms.com/ftopict-12172.html

CCSVI: Two months after

0

After further examination (triplex of jugular veins) my veins are still open and in perfect health. The triplex showed no restenosis and excellent flow. We observed again the membranes in the left and right jugular but it was only the remains of what was left after they were torn during the liberation procedure.

Approximately 72 days of ups and downs there seems to be a more steady improvement: 1. Greater strength in walking is a clear and a more standing position while walking as well. Bending legs easier, less feeling of heaviness. 2. No dizziness after swimming. 3. Very deep More >

Tysabri: Deadly brain infection known as PML

0
Not only they don’t cure you, they destroy your brain!!! Even FDA admits that “Frequent Tysabri Use Raises PML Risk”. Follow the links below.
The following article is taken from Reuters

* Says 6 new PML cases as of June 7th

* Total PML cases stand at 55, up from 49 as of May 6th

BOSTON, June 17 (Reuters) – Six more patients taking Biogen Idec Inc’s (BIIB.O) multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company said.

The Cambridge, Massachusetts-based biotechnology company said in its latest monthly update

More >

Go to Top